PHYSIOLOGICAL ACTIVITY OF PLATELET ACTIVATING FACTOR(PAF) AND ANTISHOCK ACTION OF THE PAF ANTAGONIST

血小板活化因子(PAF)的生理活性及PAF拮抗剂的抗休克作用

基本信息

  • 批准号:
    62570699
  • 负责人:
  • 金额:
    $ 1.15万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1987
  • 资助国家:
    日本
  • 起止时间:
    1987 至 1988
  • 项目状态:
    已结题

项目摘要

Platelet activating factor (PAF) produces shock in animals and has been implicated in the pathogenesis of experimental endotoxin shock. LTs have also been suggested as key mediators in a number of pathologic processes including vasopermeability and cardiac dysfunction. These two substances have also strong interaction in their synthetic pathway and biological activities. We have studied the effect of specific PAF receptor antagonists (CV-3988,CV-6208) and LTs antagonists (FPL-55712,ONO-1708) on endotoxin-induced systemic reactions and survival rate in rats. Pretreatment with CV or FPL did not prevent the change of plasma transaminase, platelet count and hematocrit following the administration of lipopolisaccharide (LPS), and it did not improve the survival rate from endotoxin shock. On the contrary, combined pretreatments of CV and FPL or ONO improved significantly the survival rates and pre-vented the increase of hematocrit following LPS administration.Four days after the administation of vinblastine (VB), white blood cell count decreased to 1200 220/mm^3. In the rats that received VB, survival rate increased significantly and prevent the change of plasma transaminase following the adminstration of LPS. These findings suggest that PAF and LT released from the white blood cells may play a pivotal role in the pathogenesis of endotoxin shock and are closely related to the hemodynamic change and vascular permeability.
血小板活化因子(PAF)在动物中产生休克,并与实验性内毒素休克的发病机制有关。lt也被认为是许多病理过程的关键介质,包括血管渗透性和心功能障碍。这两种物质在合成途径和生物活性上也有很强的相互作用。我们研究了特异性PAF受体拮抗剂(CV-3988、CV-6208)和LTs拮抗剂(FPL-55712、ONO-1708)对内毒素诱导的大鼠全身反应和存活率的影响。CV或FPL预处理不能预防内毒素休克后血浆转氨酶、血小板计数和红细胞压积的变化,也不能提高内毒素休克的存活率。相反,CV和FPL或ONO联合预处理显著提高了存活率,并阻止了LPS给药后红细胞压积的增加。给予长春花碱(VB) 4 d后,白细胞计数降至1200 220/mm^3。注射VB的大鼠存活率明显提高,且LPS对血浆转氨酶无明显影响。这些结果提示,白细胞释放的PAF和LT可能在内毒素休克的发病机制中起关键作用,并与血流动力学改变和血管通透性密切相关。

项目成果

期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
後藤文夫: 麻酔. 37. 2-15 (1988)
后藤文雄:麻醉。 37. 2-15 (1988)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Goto, F.: "Prostaglandins and related compunds" Japanese J. Anesthesia (MASUI). 37. 2-15 (1988)
Goto, F.:“前列腺素和相关化合物”日本麻醉学杂志 (MASUI)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
後藤文夫 他: 医学のあゆみ. 147. 133-134 (1988)
Fumio Goto 等人:医学史。147. 133-134 (1988)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉川大輔,後藤文夫: 麻酔. 37. 1460ー1465 (1988)
吉川大辅,后藤文雄:麻醉,37。1460-1465 (1988)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GOTO Fumio其他文献

GOTO Fumio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GOTO Fumio', 18)}}的其他基金

Good Governance under One Party SystemIn the case of China, Vietnam, Laos, Cambodia
一党制下的善治——以中国、越南、老挝、柬埔寨为例
  • 批准号:
    22402019
  • 财政年份:
    2010
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Intracellular signal transduction and axonal transport after nerve injury, and during nerve regeneration.
神经损伤后和神经再生过程中的细胞内信号转导和轴突运输。
  • 批准号:
    14370481
  • 财政年份:
    2002
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Interaction between physiological activity and molecular form of natriuretic peptide
利尿钠肽的生理活性与分子形式之间的相互作用
  • 批准号:
    08671768
  • 财政年份:
    1996
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanism of natriuretic diuresis induced by natriuretic peptide
利钠肽诱导利尿钠利尿的机制
  • 批准号:
    06671551
  • 财政年份:
    1994
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Protection against endotoxin shock though stabilization of macrophages by platelet-derived factors
通过血小板衍生因子稳定巨噬细胞来防止内毒素休克
  • 批准号:
    17K08393
  • 财政年份:
    2017
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of molecular mechanism of orexin on the brain in endotoxin shock
阐明内毒素休克脑内食欲素的分子机制
  • 批准号:
    16K08541
  • 财政年份:
    2016
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Inhibition of Prolyl Hydroxylase Improves Myocardial Dysfunction Following Endotoxin Shock via Activation of Kynurenic Acid Production
抑制脯氨酰羟化酶通过激活犬尿酸生成改善内毒素休克后的心肌功能障碍
  • 批准号:
    16K20400
  • 财政年份:
    2016
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Investigation of the mechanism of low-affinity anti-histone H1 monoclonal antibody that rescues mice from lethal endotoxin shock
低亲和力抗组蛋白H1单克隆抗体拯救小鼠致死性内毒素休克的机制研究
  • 批准号:
    26861531
  • 财政年份:
    2014
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
The effect of extracellular ATP on LPS-induced endotoxin shock in mice.
细胞外 ATP 对 LPS 诱导的小鼠内毒素休克的影响。
  • 批准号:
    21790381
  • 财政年份:
    2009
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
The effect of resolvin D1 on D-galactosamine-primed endotoxin shock model in mice.
Resolvin D1 对小鼠 D-半乳糖胺引发的内毒素休克模型的影响。
  • 批准号:
    20790341
  • 财政年份:
    2008
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
C1 INHIBITOR-MEDIATED PROTECTION FROM ENDOTOXIN SHOCK
C1 抑制剂介导的内毒素休克保护
  • 批准号:
    7173831
  • 财政年份:
    2005
  • 资助金额:
    $ 1.15万
  • 项目类别:
C1 INHIBITOR-MEDIATED PROTECTION FROM ENDOTOXIN SHOCK
C1 抑制剂介导的内毒素休克保护
  • 批准号:
    7392241
  • 财政年份:
    2005
  • 资助金额:
    $ 1.15万
  • 项目类别:
C1 INHIBITOR-MEDIATED PROTECTION FROM ENDOTOXIN SHOCK
C1 抑制剂介导的内毒素休克保护
  • 批准号:
    6917375
  • 财政年份:
    2005
  • 资助金额:
    $ 1.15万
  • 项目类别:
C1 INHIBITOR-MEDIATED PROTECTION FROM ENDOTOXIN SHOCK
C1 抑制剂介导的内毒素休克保护
  • 批准号:
    7544502
  • 财政年份:
    2005
  • 资助金额:
    $ 1.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了